Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AMRUTANJAN | NSE
-6.85
-0.87%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
17/09/2024
779.25
790.00
790.00
777.95
Amrutanjan Health Care Limited manufactures supplies and sells ayurvedic pain balms non-alcoholic beverages and sanitary napkins. The company operates through OTC Products Beverages and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions body pain gels and joint muscle sprays. The company offers congestion management products that consists of cold rubs cough syrups nasal inhalers and swas mints. It also provides sanitary napkins for women. In addition the company offers corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names as well as operates a pain management center. It exports its products to the Middle East Africa Southeast Asia and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
11.8%1 month
29.0%3 months
28.8%6 months
35.7%53.49
59.88
7.89
0.01
0.00
30.38
4.93
-
485.17M
22.51B
268.89M
0.92
2.34
-33.10
7.50
15.53
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
63.90
Range1M
126.50
Range3M
155.25
Rel. volume
0.19
Price X volume
17.76M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Syncom Formulations (India) Limited | SYNCOMF | Drug Manufacturers-Specialty & Generic | 23.86 | 22.81B | -4.22% | 83.97 | 25.16% |
Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 2453.25 | 20.90B | 0.82% | 104.10 | 83.75% |
Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 895.3 | 18.77B | 1.57% | 31.83 | 0.81% |
Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 773.5 | 15.52B | 2.17% | 15.67 | 0.18% |
Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 131.38 | 13.80B | -2.06% | 17.47 | 10.32% |
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 399.15 | 11.15B | 4.16% | n/a | 119.57% |
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 47.86 | 11.03B | -2.09% | 201.62 | 59.44% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 410.1 | 10.85B | 0.05% | 53.99 | 4.77% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1481.35 | 8.45B | -1.90% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 256.19 | 8.40B | 1.93% | 16.51 | 416.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Signpost India Limited | SIGNPOST | Advertising Agencies | 227.83 | 23.44B | -0.81% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 109.13 | 3.49B | 4.60% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 169.14 | 1.88B | 5.00% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 98.53 | 1.41B | -0.47% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 37.62 | 1.05B | -0.11% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.04 | 481.85M | -0.85% | 88.75 | 43.14% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 15.73 | 355.84M | -5.58% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.1 | 306.88M | -0.20% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 30.38 | - | Expensive |
Ent. to Revenue | 4.93 | - | Cheaper |
PE Ratio | 53.49 | 47.84 | Par |
Price to Book | 7.89 | 6.55 | Expensive |
Dividend Yield | 0.92 | - | Leader |
Std. Deviation (3M) | 28.84 | - | Lower Risk |
Debt to Equity | 0.01 | 0.34 | Cheaper |
Debt to Assets | 0.00 | 0.17 | Cheaper |
Market Cap | 22.51B | - | Emerging |